Over 70% of automakers reported month-on-month sales growth in August, bottoming out during the off-season to build momentum for the "Golden September, Silver October" peak period.
① In August, retail sales of passenger vehicles in the national market reached 1.541 million units, a year-on-year decrease of 23.6% and a month-on-month increase of 5.5%; ② Passenger vehicle exports (including complete vehicles and CKD) totaled 888,000 units in August, representing a year-on-year increase of 77.8%; ③ BYD, SAIC Motor, and Geely Auto ranked as the top three sellers in August, with all three companies achieving significant growth in their overseas export businesses.
The AI Short-Drama Boom: Everyone Can "Produce" Dramas—Costs Are Easy to Cut, but Profits Are Hard to Earn | Investigation
①AI‑driven short-form dramas have slashed production costs from the million‑yuan range down to just tens of thousands, with 9.9‑yuan crash courses selling tens of thousands of copies and attracting
Samsung to debut its self-developed robot in January 2027 as the robotics industry enters a phase of large-scale commercialization.
① Samsung Electronics is accelerating the development of its humanoid robot prototype, with the goal of publicly unveiling its self-developed humanoid robot for the first time at CES 2027, the world's largest consumer electronics exhibition, to be held in Las Vegas, United States, in January 2027. ② The Shi Jinman team at Yinhe Auto pointed out that the mass deployment of domestic humanoid robots is accelerating, accounting for 97% of global shipments in the first half of the year, indicating that the industry has entered a phase of large-scale commercial implementation.
Announcement from a stock with two consecutive daily gains: AI business generated only about 80 yuan in revenue in June | Selected After-Hours Announcements
A stock with two consecutive daily gains announced that its AI business generated only about 80 yuan in revenue in June; a subsidiary of a leading export-oriented stock received over 360 million yuan in "tariff refunds"; brokerages' "aircraft carrier-level" restructuring approved...
No specific orders have been finalized in the cooperation with CATL! 20CM PCB concept stock issues announcement on unusual trading activity | Post-market announcements roundup
Xinhua Media: Planning to issue shares to acquire controlling stake in Jiemian Cailianshe and suspends trading
Day 3 of the 2026 National Reimbursement Drug List (NRDL) negotiations: Intensive talks on new "-tinib" drugs as star companies such as BeiGene and Kelun Biotech take the stage.
1) Intensive negotiations for new "-tinib" class drugs took place in the morning, with innovative pharmaceutical companies such as InnoCare Pharma, Shouyao Holdings, and Jiangsu Wellshine making successive appearances; 2) In the afternoon session, leading pharmaceutical firms including Kelun Biotech and BeiGene were featured, engaging in a two-pronged strategic dynamic in the ADC sector characterized by "expansion within the catalog" and "new additions outside the catalog."